Monitoring Effects of Anti-Tg Antibody Increase with Regards to Laboratory Implications and Solution Recommendations

Journal Title: Nuclear Medicine Seminars - Year 2021, Vol 7, Issue 1

Abstract

Thyroglobulin (Tg) is widely used as a biochemical tumor marker in the post-treatment follow-up of differentiated thyroid cancer patients. Tg measurement is usually done by immunometric analyzes (IMA). However false negativity is the disadvantage of IMA methods in Tg antibody positive patients. Recently, methods using mass spectrometry to detect Tg have been developed to overcome this interference. In all cases for whom Tg test is requested, serum antithyroglobulin autoantibodies (TgAb) should also be measured for the reliability of Tg measurements made by immune analysis. Tg results measured by IMA will not be reliable if samples are positive for TgAb, then Tg should be measured using MS method as a reflex strategy. It is suggested that the RIA method is resistant to TgAb interference and Tg can be measured with this method in lack of possibility performing MS method. However, it is crucial to keep in mind that the radioimmun assay (RIA) method is also susceptible to diverse interferences. If there is no possibility for verification of Tg through RIA or MS method in TgAb positive patients, Tg test should not be used to monitor residue or recurrence. In this case, TgAb is used as a surrogate tumor marker instead of Tg, and interpretation is made according to the change of TgAb levels during the follow-up. TgAb measurement is performed by immunoassay, nevertheless, there are various limitations of these methods. In spite of the internationally recommended standards, which used in measurements of TgAb, the results between methods may show inconsistence with each other due to some matters include the analytical performances of the methods such as sensitivity/specificity, the difference in threshold values and the heterogeneous structure of TgAbs present in cancer patients. In conclusion, TgAb follow-up should be done with the same measurement method; threshold values should be used for evaluating the test results, the results should not be compared with each other and the clinician must be informed about the method alterations. In addition, there may be various interferences that may cause false negativity or false positivity in immune methods used in TgAb measurements as in Tg measurements. Interference investigation for clinically incompatible results, should be performed and the results always evaluated together with the clinical situation.

Authors and Affiliations

Özlem Gülbahar

Keywords

Related Articles

How Use of Radioiodine Is Changing According to Risk Groups in Well Differentiated Thyroid Cancer?

Many aspects of patient management in thyroid cancers including I-131 use are based on retrospective data or expert opinions and still debatable. With the increasing use of ultrasonography, demographics of thyroid cancer...

Procedure Guideline for Scintigraphic Imaging in Cardiac Transthyretin Amyloidosis

Amyloidosis is a multisystem disease that results from extracellular deposition of amyloid fibriles in tissue and cardiac involvement may be seen. Cardiac amyloidosis is a rare and mostly underdiagnosed cause of heart fa...

Myocardial Perfusion SPECT Procedure Guideline

After Turkish Society of Nuclear Medicine “Cardiology Group” had first published “Nuclear Cardiology Practice Guidelines” in 2001, in line particular with the technological developments, significant changes both in the h...

Imaging Guideline in Pediatric Neuroblastoma Patients

The aim of this procedure guideline is the standardization of I-123 metaiodobenzylguanidine scintigraphy, F-18 fluorodeoxyglucose, F-18 fluoropheniylalanine, Ga-68 DOTA peptide positron emission tomography/computerized t...

The Expectations of Pediatric Urologists from Nuclear Medicine

Nuclear medicine is frequently used by pediatric urologists. Treatment planning of ureterovesical junction obstruction, vesicoureteral reflux, and similar common congenital anomalies can only be done with well-reported n...

Download PDF file
  • EP ID EP693438
  • DOI 10.4274/nts.galenos.2021.0004
  • Views 88
  • Downloads 0

How To Cite

Özlem Gülbahar (2021). Monitoring Effects of Anti-Tg Antibody Increase with Regards to Laboratory Implications and Solution Recommendations. Nuclear Medicine Seminars, 7(1), -. https://europub.co.uk./articles/-A-693438